Bouma-de Krijger A - Search Results

1

Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients.

Buiten MS, de Bie MK, Bouma-de Krijger A, van Dam B, Dekker FW, Jukema JW, Rabelink TJ, Rotmans JI. Buiten MS, et al. Among authors: bouma de krijger a. BMC Nephrol. 2014 Dec 11;15:197. doi: 10.1186/1471-2369-15-197. BMC Nephrol. 2014. PMID: 25495997 Free PMC article.

2

Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.

Bech AP, Bouma-de Krijger A, van Zuilen AD, Bots ML, van den Brand JA, Blankestijn PJ, Wetzels JF, Vervloet MG. Bech AP, et al. Among authors: bouma de krijger a. J Nephrol. 2015 Aug;28(4):477-84. doi: 10.1007/s40620-015-0178-0. Epub 2015 Feb 21. J Nephrol. 2015. PMID: 25700931 Free PMC article. Clinical Trial.

3

Fibroblast growth factor 23: are we ready to use it in clinical practice?

Bouma-de Krijger A, Vervloet MG. Bouma-de Krijger A, et al. J Nephrol. 2020 Jun;33(3):509-527. doi: 10.1007/s40620-020-00715-2. Epub 2020 Mar 4. J Nephrol. 2020. PMID: 32130720 Free PMC article. Review.

4

Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease.

Bouma-de Krijger A, Bots ML, Vervloet MG, Blankestijn PJ, Ter Wee PW, van Zuilen AD, Wetzels JF. Bouma-de Krijger A, et al. Nephrol Dial Transplant. 2014 Jan;29(1):88-97. doi: 10.1093/ndt/gft456. Epub 2013 Nov 8. Nephrol Dial Transplant. 2014. PMID: 24215017 Clinical Trial.

5

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis.

Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, Landray MJ, Moe SM, Yang J, Holland L, di Giuseppe R, Bouma-de Krijger A, Mihaylova B, Herrington WG. Marthi A, et al. Among authors: bouma de krijger a. J Am Soc Nephrol. 2018 Jul;29(7):2015-2027. doi: 10.1681/ASN.2017121334. Epub 2018 May 15. J Am Soc Nephrol. 2018. PMID: 29764921 Free PMC article. Review.

6

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3.

Bouma-de Krijger A, van Ittersum FJ, Hoekstra T, Ter Wee PM, Vervloet MG. Bouma-de Krijger A, et al. Clin Kidney J. 2019 Mar 25;12(5):678-685. doi: 10.1093/ckj/sfz027. eCollection 2019 Oct. Clin Kidney J. 2019. PMID: 31584563 Free PMC article.

7

Change in FGF23 concentration over time and its association with all-cause mortality in patients treated with haemodialysis or haemodiafiltration.

Bouma-de Krijger A, de Roij van Zuijdewijn CLM, Nubé MJ, Grooteman MPC, Vervloet MG; CONTRAST Study Group. Bouma-de Krijger A, et al. Clin Kidney J. 2020 Apr 1;14(3):891-897. doi: 10.1093/ckj/sfaa028. eCollection 2021 Mar. Clin Kidney J. 2020. PMID: 33777372 Free PMC article.

8

Neurosyphilis mimicking giant cell arteritis both clinically and microscopically.

van Ruitenbeek N, van Kasteren M, Bouma-de Krijger A. van Ruitenbeek N, et al. Among authors: bouma de krijger a. BMJ Case Rep. 2022 May 31;15(5):e247642. doi: 10.1136/bcr-2021-247642. BMJ Case Rep. 2022. PMID: 35641087 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters